- Home
- WABC vs QURE Comparison
WABC vs QURE Comparison
Compare WABC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WABC | QURE |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WABC | QURE |
|---|---|---|
| Price | $54.11 | $20.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $54.00 | $45.00 |
| AVG Volume (30 Days) | 155.4K | ★ 1.5M |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ 3.40 | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | N/A | $126.12 |
| Revenue Next Year | N/A | $200.43 |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $44.93 | $8.73 |
| 52 Week High | $56.22 | $71.50 |
Technical Indicators
Market Signals| Indicator | WABC | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 62.32 |
| Support Level | $46.47 | $19.73 |
| Resistance Level | $55.64 | $25.66 |
| Average True Range (ATR) | 1.37 | 1.30 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 58.08 | 93.80 |
Price Performance
Historical ComparisonAbout WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.